ACR 0.00% 5.4¢ acrux limited

Also back in June 2014 the FDA added a label change requirement...

  1. 150 Posts.
    lightbulb Created with Sketch. 3
    Also back in June 2014 the FDA added a label change requirement to testosterone products covering potential venous blood clots: http://www.fda.gov/Drugs/DrugSafety/ucm401746.htm

    At the time I chatted with a senior intensive care doctor (ie. knows a lot about old people) about it. She advised that it made no difference because any decent doctor already knows that testosterone increases red blood cell count thereby thickening the blood. Doctors would already be taking into account this when prescribing testosterone.

    Same should also apply to the latest labelling requirement. A doctor should already be across all the pros and cons before prescribing the stuff. Any doctor worth their salt that it is. And, speaking of salt, doesn't that potentially increase chance of stroke. Where's the warning label?!?
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
0.000(0.00%)
Mkt cap ! $15.69M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 60019 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 225945 1
View Market Depth
Last trade - 16.12pm 18/09/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.